翁翠莲,刘庆华,林兴盛,石松长. 急性肺损伤MMP-2 mRNA变化及地塞米松的保护作用[J]. 中国急救医学, 2018, 38(8): 728-731.
Weng Cui-lian, Liu Qing-hua, Lin Xing-sheng, Shi Song-chang. The expression of MMP-2 mRNA in endotoxin-induced acute lung injury and the protective effects of dexamethasone. Chinese Journal of Critical Care Medicine, 2018, 38(8): 728-731.
[1]Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment[J]. Annu Rev Pathol, 2011, 6: 147-163.
[2]Li X, Zheng Z, Ma XC. Effects of unfractionated heparin on expression of metalloproteinase-2 and-9 in acute lung injury rats[J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2012, 24(10):608-611.
[3]Liu J, Khalil RA. Matrix metalloproteinase inhibitors as investigational and therapeutic tools in unrestrained tissue remodeling and pathological disorders[J]. Prog Mol Biol Transl Sci, 2017, 148:355-420.
[4]Villalta PC, Rocic P, Townsley MI. Role of MMP2 and MMP9 in TRPV4-induced lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2014, 307(8):652-659.
[5]Aschner Y, Zemans RL, Yamashita CM, et al. Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS[J]. Chest, 2014, 146(4):1081-1091.
[6]Wang J, Zhang H, Su C, et al. Dexamethasone ameliorates HS-induced acute lung injury by alleviating matrix metalloproteinase-2 and-9 expression[J]. PLoS One, 2014, 9(4):e94 701.
[7]Warner RL, Lewis CS, Beltran L, et al. The role of metalloelastase in immune complex-induced acute lung injury[J]. Am J Pathol, 2001, 158(6):2139-2144.